UNSPSC 51352302: Cloxestradiol

This classification denotes a therapeutic estrogen with the molecular formula C20H25Cl3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42R9MZG1DL, chemically known as 17 beta-(2,2,2-trichloro-1-hydroxyethoxy)estra-1,3,5(10)-trien-3-ol. but generally known as cloxestradiol, which bears US NIH Compound Identifier 194705. European Medicines Agency schedules Cloxestradiol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06782MIG. The term CLOXESTRADIOL is an International Non-Proprietary Name.

UNSPSC 51352302 Cloxestradiol, a Commodity code, names a specific pharmaceutical compound used in hormone replacement and veterinary applications, but state and local governments show minimal recent procurement activity under this code. The pharmaceutical and veterinary supply markets are dominated by federal procurement and private-sector commercial purchasing; state and local agencies rarely issue standalone solicitations for individual active pharmaceutical ingredients at the commodity level.

No recent state and local contract opportunities appear under this code. State and local procurement activity in the broader pharmaceutical and medical-supplies space typically occurs at higher UNSPSC tiers (Family and Class levels) and clusters around general medical supplies, vaccines, and OTC medications rather than specific pharmaceutical compounds. If pursuing work in this space, monitor Class and Family codes covering general pharmaceutical procurement and veterinary medicines through state health departments, correctional-facility health services, and animal-control or agricultural agencies.